UniProt ID | TRI47_HUMAN | |
---|---|---|
UniProt AC | Q96LD4 | |
Protein Name | Tripartite motif-containing protein 47 | |
Gene Name | TRIM47 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 638 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | ||
Protein Sequence | MDGSGPFSCPICLEPLREPVTLPCGHNFCLACLGALWPHRGASGAGGPGGAARCPLCQEPFPDGLQLRKNHTLSELLQLRQGSGPGSGPGPAPALAPEPSAPSALPSVPEPSAPCAPEPWPAGEEPVRCDACPEGAALPAALSCLSCLASFCPAHLGPHERSPALRGHRLVPPLRRLEESLCPRHLRPLERYCRAERVCLCEACAAQEHRGHELVPLEQERALQEAEQSKVLSAVEDRMDELGAGIAQSRRTVALIKSAAVAERERVSRLFADAAAALQGFQTQVLGFIEEGEAAMLGRSQGDLRRQEEQRSRLSRARQNLSQVPEADSVSFLQELLALRLALEDGCGPGPGPPRELSFTKSSQAVRAVRDMLAVACVNQWEQLRGPGGNEDGPQKLDSEADAEPQDLESTNLLESEAPRDYFLKFAYIVDLDSDTADKFLQLFGTKGVKRVLCPINYPLSPTRFTHCEQVLGEGALDRGTYYWEVEIIEGWVSMGVMAEDFSPQEPYDRGRLGRNAHSCCLQWNGRSFSVWFHGLEAPLPHPFSPTVGVCLEYADRALAFYAVRDGKMSLLRRLKASRPRRGGIPASPIDPFQSRLDSHFAGLFTHRLKPAFFLESVDAHLQIGPLKKSCISVLKRR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 (in isoform 2) | Acetylation | - | 13.70 | 22814378 | |
19 | Ubiquitination | CLEPLREPVTLPCGH CCCCCCCCEEECCCC | 20.26 | 21963094 | |
72 | Phosphorylation | LQLRKNHTLSELLQL CHHCCCCCHHHHHHH | 41.18 | 26657352 | |
74 | Phosphorylation | LRKNHTLSELLQLRQ HCCCCCHHHHHHHHC | 27.61 | 28555341 | |
123 | Ubiquitination | APEPWPAGEEPVRCD CCCCCCCCCCCCCCC | 35.40 | - | |
123 | Ubiquitination | APEPWPAGEEPVRCD CCCCCCCCCCCCCCC | 35.40 | 27667366 | |
158 | Ubiquitination | FCPAHLGPHERSPAL HCCHHHCCCCCCHHH | 32.31 | - | |
158 | Ubiquitination | FCPAHLGPHERSPAL HCCHHHCCCCCCHHH | 32.31 | 21963094 | |
162 | Phosphorylation | HLGPHERSPALRGHR HHCCCCCCHHHCCCC | 16.13 | 28348404 | |
180 | Phosphorylation | PLRRLEESLCPRHLR CHHHHHHHHCHHHCH | 26.37 | 28857561 | |
209 | Ubiquitination | EACAAQEHRGHELVP HHHHCCCCCCCCCCC | 29.01 | - | |
209 | Ubiquitination | EACAAQEHRGHELVP HHHHCCCCCCCCCCC | 29.01 | 22817900 | |
212 | Ubiquitination | AAQEHRGHELVPLEQ HCCCCCCCCCCCHHH | 25.77 | 22817900 | |
230 | Ubiquitination | LQEAEQSKVLSAVED HHHHHHHHHHHHHHH | 47.06 | 21906983 | |
233 | Phosphorylation | AEQSKVLSAVEDRMD HHHHHHHHHHHHHHH | 33.00 | 20068231 | |
257 | Ubiquitination | RRTVALIKSAAVAER HHHHHHHHHHHHHHH | 34.59 | 21906983 | |
258 | Phosphorylation | RTVALIKSAAVAERE HHHHHHHHHHHHHHH | 17.92 | 28176443 | |
329 | Phosphorylation | SQVPEADSVSFLQEL HCCCCHHHHHHHHHH | 27.06 | - | |
330 | Ubiquitination | QVPEADSVSFLQELL CCCCHHHHHHHHHHH | 4.89 | - | |
330 | Ubiquitination | QVPEADSVSFLQELL CCCCHHHHHHHHHHH | 4.89 | 21963094 | |
331 | Phosphorylation | VPEADSVSFLQELLA CCCHHHHHHHHHHHH | 24.96 | 27251275 | |
358 | Phosphorylation | PGPPRELSFTKSSQA CCCCCCCCCCCHHHH | 26.56 | 24719451 | |
360 | Phosphorylation | PPRELSFTKSSQAVR CCCCCCCCCHHHHHH | 27.00 | 27251275 | |
361 | Ubiquitination | PRELSFTKSSQAVRA CCCCCCCCHHHHHHH | 46.21 | 21906983 | |
372 | Ubiquitination | AVRAVRDMLAVACVN HHHHHHHHHHHHHHH | 1.49 | - | |
372 | Ubiquitination | AVRAVRDMLAVACVN HHHHHHHHHHHHHHH | 1.49 | 21963094 | |
390 | Ubiquitination | QLRGPGGNEDGPQKL HHCCCCCCCCCCCCC | 50.53 | - | |
390 | Ubiquitination | QLRGPGGNEDGPQKL HHCCCCCCCCCCCCC | 50.53 | 23503661 | |
391 | Ubiquitination | LRGPGGNEDGPQKLD HCCCCCCCCCCCCCC | 68.56 | - | |
391 | Ubiquitination | LRGPGGNEDGPQKLD HCCCCCCCCCCCCCC | 68.56 | 23503661 | |
396 | Sumoylation | GNEDGPQKLDSEADA CCCCCCCCCCCCCCC | 58.35 | - | |
396 | Ubiquitination | GNEDGPQKLDSEADA CCCCCCCCCCCCCCC | 58.35 | 21906983 | |
398 | Ubiquitination | EDGPQKLDSEADAEP CCCCCCCCCCCCCCC | 52.01 | - | |
398 | Ubiquitination | EDGPQKLDSEADAEP CCCCCCCCCCCCCCC | 52.01 | 21963094 | |
399 | Phosphorylation | DGPQKLDSEADAEPQ CCCCCCCCCCCCCCC | 45.16 | - | |
410 | Phosphorylation | AEPQDLESTNLLESE CCCCCHHHCCCCCCC | 29.87 | 28555341 | |
447 | Acetylation | FLQLFGTKGVKRVLC HHHHHCCCCCCEEEE | 63.18 | 20167786 | |
447 | Ubiquitination | FLQLFGTKGVKRVLC HHHHHCCCCCCEEEE | 63.18 | 22817900 | |
450 | Ubiquitination | LFGTKGVKRVLCPIN HHCCCCCCEEEECCC | 45.52 | 22817900 | |
458 | Phosphorylation | RVLCPINYPLSPTRF EEEECCCCCCCCCCC | 13.28 | 24732914 | |
461 | Phosphorylation | CPINYPLSPTRFTHC ECCCCCCCCCCCCCH | 21.52 | 28731282 | |
463 | Phosphorylation | INYPLSPTRFTHCEQ CCCCCCCCCCCCHHH | 34.73 | 21815630 | |
568 | Ubiquitination | FYAVRDGKMSLLRRL HHHHHCCCHHHHHHH | 29.61 | 21963094 | |
582 | Methylation | LKASRPRRGGIPASP HHHCCCCCCCCCCCC | 50.82 | 24129315 | |
588 | Phosphorylation | RRGGIPASPIDPFQS CCCCCCCCCCCHHHH | 19.62 | 29255136 | |
595 | Phosphorylation | SPIDPFQSRLDSHFA CCCCHHHHHHHHHHH | 34.88 | 23403867 | |
599 | Phosphorylation | PFQSRLDSHFAGLFT HHHHHHHHHHHHHHH | 25.70 | 20873877 | |
610 | Ubiquitination | GLFTHRLKPAFFLES HHHHCCCCHHHHHHH | 33.97 | 21963094 | |
628 | Ubiquitination | HLQIGPLKKSCISVL HHCCCCCHHHHHHHH | 45.86 | 23503661 | |
629 | Ubiquitination | LQIGPLKKSCISVLK HCCCCCHHHHHHHHH | 59.24 | 23503661 | |
630 | Phosphorylation | QIGPLKKSCISVLKR CCCCCHHHHHHHHHC | 18.33 | 27251275 | |
633 | Phosphorylation | PLKKSCISVLKRR-- CCHHHHHHHHHCC-- | 26.23 | 24719451 | |
636 | Ubiquitination | KSCISVLKRR----- HHHHHHHHCC----- | 43.93 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRI47_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI47_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI47_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
TRIM8_HUMAN | TRIM8 | physical | 22493164 | |
ANS1A_HUMAN | ANKS1A | physical | 22863883 | |
DNPEP_HUMAN | DNPEP | physical | 22863883 | |
GANAB_HUMAN | GANAB | physical | 22863883 | |
PTN12_HUMAN | PTPN12 | physical | 22863883 | |
TENS3_HUMAN | TNS3 | physical | 22863883 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-588, AND MASSSPECTROMETRY. |